$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hepatobiliary
Hepatobiliary
丙肝患者在生活中如何保健?
2025-10-19 11:44:20
Check Details
瑞士采取措施努力消除丙肝
2025-10-19 11:44:20
Check Details
丙肝新药治丙肝可改善肝硬化
2025-10-19 11:44:20
Check Details
丙肝的疾病特征有哪些?
2025-10-19 11:44:20
Check Details
丙肝伴晚期纤维化患者用新药治愈率高
2025-10-19 11:44:20
Check Details
吉三代该如何服用?
2025-10-19 11:44:20
Check Details
DAA药物,开创了丙肝治疗新时代
2025-10-19 11:44:20
Check Details
丙肝抗病毒治疗改善血液透析患者的生存率
2025-10-19 11:44:20
Check Details
索非+达卡最佳丙肝治疗组合
2025-10-19 11:44:20
Check Details
HCV和HIV合并感染患者丙肝新药治疗治愈率超过93%
2025-10-19 11:44:20
Check Details
美国孕妇丙肝感染率上升
2025-10-19 11:44:20
Check Details
DAA药物治疗丙肝效果显著
2025-10-19 11:44:20
Check Details
1
2
...
239
240
241
242
243
244
245
...
505
506
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
2
A Precision FGFR Inhibitor for Cholangiocarcinoma
3
Best time to take Luqu Bopa (Wenkedake) and precautions
4
Is defibrotide included in medical insurance?
5
When was defibrinoside launched on the market?
6
Will defibrination be reimbursed by medical insurance?
7
What conditions is defibrinoside suitable for treating?
8
What is the therapeutic effect of defibrotide?
9
How should defibrinoside be used?
10
What is the effect of defibrotide?
11
Defibrinoside Detailed Instructions
12
What is the effect of defibrination?